Investigation of cellular effects of thymoquinone on glioma cell

Eray Metin Guler1,2,3, Behice Hande Sisman4, Abdurrahim Kocyigit2,3

  • 1Department of Medical Biochemistry, Faculty of Hamidiye Medicine, University of Health Sciences Turkey, Istanbul, Turkey.

Toxicology Reports
|January 25, 2021
PubMed

Insights

Thymoquinone (TQ) exhibits anti-cancer properties against glioma cells by inducing DNA damage, apoptosis, and reactive oxygen species. This natural compound shows potential as an effective treatment for glioma, warranting further investigation.

Area of Science:

  • * Oncology
  • * Molecular Biology
  • * Pharmacology

Background:

  • * Glioblastoma is an aggressive brain tumor with a poor prognosis despite intensive treatments.
  • * Thymoquinone (TQ) demonstrates anti-cancer effects, but its precise molecular mechanisms in glioma remain unclear.
  • * Existing research on TQ's effects on glial tumors is limited, necessitating further investigation.

Purpose of the Study:

  • * To investigate the genotoxic, apoptotic, and cytotoxic effects of Thymoquinone (TQ) on C6 rat glioma cells.
  • * To elucidate the molecular mechanisms underlying TQ's anti-cancer activity in glioma.
  • * To evaluate TQ's impact on intracellular reactive oxygen species (iROS), mitochondrial membrane potential (MMP), glutathione (GSH) levels, and calcium signaling.

Main Methods:

  • * Cytotoxicity assessed via ATP cell viability assay.
  • * Genotoxicity evaluated using the comet assay.
  • * iROS, MMP, GSH, and calcium levels measured using specific assays (H2DCF-DA, DiOC6(3), GSH/GSSG-Glo, Fura-2AM).
  • * Apoptosis induction analyzed through acridine orange/ethidium bromide staining, flow cytometry, and Western blotting.
  • * Protein levels of Caspase-3, Caspase-9, Bax, Bcl-2, and pSTAT3 determined by Western blotting.

Main Results:

  • * TQ demonstrated a dose-dependent increase in cytotoxicity against C6 glioma cells.
  • * TQ induced significant DNA damage, apoptosis, and elevated intracellular reactive oxygen species (iROS).
  • * TQ treatment led to decreased mitochondrial membrane potential (MMP) and glutathione (GSH) levels.
  • * TQ inhibited pSTAT3 signaling, modulating pro-apoptotic (Bax) and anti-apoptotic (Bcl-2) proteins to promote apoptosis.

Conclusions:

  • * Thymoquinone exhibits potent cytotoxic, genotoxic, and apoptotic effects on C6 rat glioma cells.
  • * TQ's mechanism involves iROS generation, MMP disruption, and pSTAT3 inhibition, leading to apoptosis.
  • * TQ shows promise as a potential therapeutic agent for glioma treatment, meriting further clinical research.

Related Concept Videos